Elevai Labs (ELAB) versus Its Competitors Critical Analysis

Elevai Labs (NASDAQ:ELABGet Free Report) is one of 1,004 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare Elevai Labs to related businesses based on the strength of its analyst recommendations, profitability, valuation, risk, institutional ownership, earnings and dividends.


This table compares Elevai Labs and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Elevai Labs -211.25% -225.32% -125.94%
Elevai Labs Competitors -2,990.49% -285.16% -33.66%

Insider and Institutional Ownership

22.2% of Elevai Labs shares are held by institutional investors. Comparatively, 44.5% of shares of all “Pharmaceutical preparations” companies are held by institutional investors. 13.9% of shares of all “Pharmaceutical preparations” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Elevai Labs and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevai Labs 0 0 0 0 N/A
Elevai Labs Competitors 6590 19067 45356 947 2.57

As a group, “Pharmaceutical preparations” companies have a potential upside of 75.68%. Given Elevai Labs’ rivals higher possible upside, analysts plainly believe Elevai Labs has less favorable growth aspects than its rivals.

Valuation & Earnings

This table compares Elevai Labs and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Elevai Labs $1.71 million -$4.30 million -1.72
Elevai Labs Competitors $1.70 billion $152.51 million -2.75

Elevai Labs’ rivals have higher revenue and earnings than Elevai Labs. Elevai Labs is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.


Elevai Labs rivals beat Elevai Labs on 6 of the 9 factors compared.

About Elevai Labs

(Get Free Report)

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.